| Aa-012M7B997-E133-2022 Medicamentos Insabi | 1.2B | 2023-01-01 |
| Se03_2020_ Ssa | 656.7M | 2020-05-20 |
| Adjudicación Directa Aa-012M7B997-E133-2022 Cons. (Ce-051Gyn007-E66-2022) | 547.3M | 2023-01-01 |
| Aa-12-512-012000991-T-176-2023 Medicamentos-Salud | 308.5M | 2024-01-01 |
| La-050Gyr047-E47-2022 Grupo 010 Medicamentos y 040 Psicotropicos | 220.0M | 2022-12-09 |
| Aa-012M7B998-E197-2021 Medicamentos Insabi | 209.5M | 2022-01-01 |
| Adjudicación Directa Aa-012000991-E70-2020 Cons. (Ce-051Gyn007-E37-2020) | 178.1M | 2020-05-07 |
| Adjudicación Directa Intern. No. Aa-051Gyn007-E52-2021, Medicamentos | 148.8M | 2021-07-29 |